Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer

[1]  G. Fan,et al.  Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ. , 2014, Biochimica et biophysica acta.

[2]  S. Ghosh,et al.  Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes , 2014, Front. Immunol..

[3]  S. Koo,et al.  CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis , 2013, BMB reports.

[4]  Yuzhuo Wang,et al.  Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer , 2013, Journal of experimental & clinical cancer research : CR.

[5]  Ying Jiang,et al.  Nemo-Like Kinase Associated with Proliferation and Apoptosis by c-Myb Degradation in Breast Cancer , 2013, PloS one.

[6]  H. Weng,et al.  Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer , 2013, Tumor Biology.

[7]  Rolf T Hansen,et al.  Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline , 2013, Brain Research.

[8]  W. Heo,et al.  p21-Activated kinase 4 promotes prostate cancer progression through CREB , 2013, Oncogene.

[9]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[10]  Jian Wang,et al.  Orphan nuclear receptor nurr1 as a potential novel marker for progression in human prostate cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[11]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[12]  J. Regan,et al.  Prostanoid EP1 receptors mediate up‐regulation of the orphan nuclear receptor Nurr1 by cAMP‐independent activation of protein kinase A, CREB and NF‐κB , 2012, British journal of pharmacology.

[13]  P. Möller,et al.  NF-κB signaling in prostate cancer: A promising therapeutic target? , 2012, World Journal of Urology.

[14]  Noula Shembade,et al.  Regulation of NF-κB signaling by the A20 deubiquitinase , 2012, Cellular and Molecular Immunology.

[15]  J. Veltman,et al.  Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. , 2012, Stem cells and development.

[16]  Dezheng Zhao,et al.  VEGF stimulates PKD‐mediated CREB‐dependent orphan nuclear receptor Nurr1 expression: Role in VEGF‐induced angiogenesis , 2011, International journal of cancer.

[17]  Yeqing Huang,et al.  Expression of NLK and Its Potential Effect in Ovarian Cancer Chemotherapy , 2011, International Journal of Gynecologic Cancer.

[18]  L. Lamb,et al.  The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling. , 2011, Cancer research.

[19]  H. Akaza,et al.  Prostate Cancer Working Group report. , 2010, Japanese journal of clinical oncology.

[20]  Y. Okazaki,et al.  Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/β‐catenin signaling , 2010, Cancer science.

[21]  R. D. de Winter,et al.  Nuclear Receptor Nurr1 Is Expressed In and Is Associated With Human Restenosis and Inhibits Vascular Lesion Formation In Mice Involving Inhibition of Smooth Muscle Cell Proliferation and Inflammation , 2010, Circulation.

[22]  J. Shim,et al.  Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival , 2010, Stem cells.

[23]  B. Czerniak,et al.  Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer , 2010, Cancer.

[24]  R. Vessella,et al.  Nemo‐like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells , 2009, The Prostate.

[25]  H. Tai,et al.  Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. , 2009, Carcinogenesis.

[26]  W. Gerald,et al.  NF-kappaB regulates androgen receptor expression and prostate cancer growth. , 2009, The American journal of pathology.

[27]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[28]  J. Chirgwin,et al.  Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.

[29]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[30]  M. Gleave,et al.  Therapeutic options for hormone-refractory prostate cancer in 2007. , 2007, Urologic oncology.

[31]  S. Terry,et al.  The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches? , 2007, World Journal of Urology.

[32]  M. Wirth,et al.  Therapieoptionen beim hormonrefraktären Prostatakarzinom , 2006, Der Urologe.

[33]  V. Holla,et al.  Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer* , 2006, Journal of Biological Chemistry.

[34]  J. Arthur,et al.  MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. , 2005, The Biochemical journal.

[35]  A. Brachat,et al.  Nuclear Hormone Receptor NR4A2 Is Involved in Cell Transformation and Apoptosis , 2004, Cancer Research.

[36]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[37]  K. Pienta,et al.  Dynamic process of prostate cancer metastasis to bone , 2004, Journal of cellular biochemistry.

[38]  J. Yasuda,et al.  Nemo‐like kinase suppresses a wide range of transcription factors, including nuclear factor‐kB , 2004, Cancer science.

[39]  B. Bresnihan,et al.  Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue1 , 2002, The Journal of Immunology.

[40]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[41]  M. Emi,et al.  Genomic structure of the human NLK (nemo-like kinase) gene and analysis of its promoter region. , 2002, Gene.

[42]  K. Miyazono,et al.  Positive and negative regulation of TGF-beta signaling. , 2000, Journal of cell science.

[43]  H. Ichinose,et al.  Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. , 1999, Gene.

[44]  R. Erikson,et al.  Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[46]  G. Nabel,et al.  Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.

[47]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[48]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[49]  M. Montminy,et al.  Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.

[50]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[51]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[52]  S. Terry,et al.  The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches? , 2007, World journal of urology.

[53]  P. Albers,et al.  [Therapeutic options for hormone-refractory prostate cancer]. , 2006, Der Urologe. Ausg. A.

[54]  S. Ghosh,et al.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. , 2002, Molecular cell.

[55]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.